Gary Horwith is listed as an executive officer on 7 SEC Form D filings by 1 issuer between Jul 2009 and Sep 2012: SEQUELLA INC. (Rockville, MD — pharmaceuticals — 2009–2012; $3.1M reported sold to 36 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Alan Klein (7 shared filings), Bradley Rotter (7 shared filings), Carol A Nacy (7 shared filings), Lawrence Miller (7 shared filings), Leo Einck (7 shared filings) and 4 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Gary. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 9 court cases matching the name, 2 bankruptcy cases matching the name listed in Key records below.
What this means 11 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 7 public filings for Gary Horwith and found 12 differences, 4 worth asking the sponsor about: Investor count went down between filings; Paid seller listed without a CRD number: Life Science Advisory Group; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.